Imatinib Terminated Phase 2 Trials for Pulmonary Hypertension (PH) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00583115Safety Study of GleevecĀ® in Children With Pulmonary Hypertension